OOIR: Observatory of International Research

Papers

(The H4-Index of Europace is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?	525
Examination of pituitary adenylate cyclase-activating polypeptide (PACAP) in patients with atrial fibrillation undergoing pulmonary vein isolation	366
Impact of pulsed-field ablation on kidney function	308
The effect of virtual reality on anxiety reduction in supraventricular tachycardia ablation: prospective study	264
Early detection of fluid retention with a multisensory algorithm in chronic heart failure patients	228
Single-chamber versus dual-chamber pacing: real world data from the German national VIDEO project	215
Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial	180
Pulmonary vein isolation with the novel radiofrequency balloon catheter: predictors of single-shot isolation	174
Coronary sinus cannulation as real time anatomical landmark to facilitate left bundle branch area pacing	158
A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: acute results from the Micra AV post-approval registry	152
Serial arterial blood gas monitoring during deep sedation for left atrial ablation procedures: a retrospective cohort study	146
CRT with triple fusion: results of the multicentric, randomized, doble-blinded CRUSTY trial	133
Extended use of preprocedural data to detect expiratory airflow limitation in patients with atrial fibrillation scheduled for ablation	116
CIED replacement optimization: feasibility, safety and acceptability of day surgery setting for CIED replacement	115
Pulsed field ablation of the left common pulmonary vein: a new single-shot solution?	113
Analysis of mitral isthmus ablation in patients undergoing a second ablation procedure after atrial fibrillation ablation with electroporation vs. radiofrequency	111
New insights from repeated extra-cardiac vagal nerve stimulation after recent successful cardioneuroablation in high risk patients with vagally-mediated bradyarrhythmias	106
New onset, recurrence and progression of atrial fibrillation after cardiac surgery during 2.5 years of continuous rhythm monitoring	105
The new "olive strategy" for pulsed field ablation of atrial fibrillation: procedural data and early follow-up	102
Volumetric quantification of epicardial fat using semiautomated atrial CT segmentation in patients with atrial fibrillation: the Prospective AFAT study	100
Implementation of near zero fluoroscopy in supraventricular tachycardia ablation procedures: a single center experience	94
High efficacy and safety of endocardial pulsed electrical field ablation via contact force-controlled catheters for mitral isthmus ablation	90
Adherence to a mobile health-based atrial fibrillation screening program: a subanalysis from STROKESTOP I and II	82
Computed tomography as a predictive tool for ventricular tachycardia	82
Rhythm matters: sinus and pace rhythm map significantly differ in endo/epicardial 3D electroanatomic mapping	79

Prevalence and risk factors of pre-procedural left atrial thrombus in patients undergoing pulmonary vein isolation	73
Ablation for idiopathic ventricular arrhythmias using focal pulsed field ablation	72
Sudden cardiac death and atrial depolarization in coronary artery disease—Authors’ reply	68
Preclinical evaluation of safety and efficacy of the Coherent Sine-Burst Electroporation (CSE) ablation system in a chronic porcine beating heart model	67
Long-term effects of catheter ablation versus antiarrhythmic drugs on health-related quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial revisited	66
Management of modifiable risk factors and comorbidities in atrial fibrillation: suggestions for improvement from a patient perspective	66
Early vs. delayed vt ablation in patients with ischemic cardiomyopathy	65
LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial	65
Atrioventricular nodal reentrant tachycardia ablation (avnrt), a female disease. insights from the german ablation registry	64
Clinical validation of an artificial intelligence algorithm offering automated corrected QT-interval measurements from a single lead electrocardiogram	62
Left atrial low-voltage areas, but not volume, predict the recurrence of atrial fibrillation in repeat ablation procedures	61
First experience of focal pulsed field ablation for premature ventricular contractions	61
Cardiac magnetic resonance - aided ventricular tachycardia substrate ablation	61
Artificial intelligence assisted QT interval measurement in 12-lead-ECGs	60
Different approaches to atrial fibrillation ablation in heart failure patients: temporal trends and clinical outcomes	59
Stiff but keeping the beat: catheter ablation for atrial fibrillation in cardiac amyloidosis and sarcoidosis	59
Hemolysis after atrial fibrillation ablation conducted with a new point-by-point pulsed field ablation device	57
Scar architecture determinants of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study	57
Optimisation of decrementing evoked potential mapping for functional substrate identification in ischaemic ventricular tachycardia ablation	56
Pacemaker dependency after Cox Maze procedure concomitant with cardiac surgery, The road between Scylla and Charybdis	55
Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion	55
MicroPort CRM considerations on Vega pacing lead performance	55
Ventricular pre-excitation in young patients: long term follow-up and natural history in a contemporary cohort	54
Conduction system pacing vs biventricular pacing in patients with left bundle branch block and resynchronization therapy indication. CONSYST-CRT trial secondary findings	53
LAT velocity vectors: a novel tool for ventricular functional substrate characterization	52
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation	52
Genetic and clinical risk factors for stroke recurrence with different impact by assessment age: data from the UK Biobank	52